Oisin Biotechnologies are developing a plasmid-based approach to destroying senescent and cancer cells. This approach may allow for higher selectivity when compared to drug approaches and could reduce side effects too.
Oisin Biotechnologies - Executive Chairman
Oisin Biotechnologies - CBO
Why we Age: Cellular Senescence
As your body ages, more of your cells become senescent. Senescent cells do not divide or support the tissues of which they are part; instead, they emit potentially harmful chemical signals, collectively known as the senescence-associated secretory phenotype (SASP), which encourages nearby cells to enter the same senescent state. Their presence causes many problems: they degrade tissue function, increase chronic inflammation, and can even eventually raise the risk of cancer and other age-related ...